Organisation paid for research Program year 2025 Source: CMS Open Payments

On-Site Clinical Solutions LLC

Neither a doctor nor a teaching hospital

Research payments

$1,179,870

463 payments

Through program year 2025, On-Site Clinical Solutions LLC is reported as receiving $1,179,870 in research payments, across 463 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $92,247 29
2024 Research $155,514 66
2023 Research $209,484 187
2022 Research $169,623 50
2021 Research $22,765 17
2020 Research $61,832 22
2019 Research $468,405 92

Breakdown

Who paid Research payments · program years 2019–2025
  1. Novo Nordisk AS $440,124 77 payments
  2. AbbVie, Inc. $421,268 110 payments
  3. F. Hoffmann-La Roche AG $105,968 15 payments
  4. Dermavant Sciences, Inc. $84,682 202 payments
  5. Allergan Inc. $67,981 30 payments
  6. Kowa Research Institute, Inc. $44,897 24 payments
  7. Genentech, Inc. $14,950 5 payments
Studies the money was for Research payments · program years 2019–2025
  1. Ex9536-4388 $108,969 12 payments
  2. Ocrelizumab in Patients With RMS $105,968 15 payments
  3. Nn1250-4252 $103,440 21 payments
  4. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) $94,493 17 payments
  5. Nn1436-4383 $88,711 12 payments
  6. Nn2211-4232 $71,734 13 payments
  7. A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) $70,701 13 payments
  8. Nn9535-4352 $62,392 16 payments
  9. Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) $53,215 17 payments
  10. A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men $48,770 20 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record